Loading clinical trials...
Loading clinical trials...
Hémorragies et Maladie Veineuse Thromboembolique du Post-partum : Epidémiologie, Etudes Des déterminants Cliniques et Biologiques
The aim of this study is to evaluate the frequencey and the determinants of postpartum major complications (hemorrhage and thrombosis) up to 3 months after delivery in the maternity hospitals of Finistère (Bretagne - France)
This is an analytical observational prospective multicenter cohort study , conducted on all the maternity hospitals in Finistère (Bretagne - France), with a biological collection. This protocol allows to study all women at risk of PPH (Postpartum Hemorrhage) and postpartum venous thromboembolic disease, including maternity level 1-3 without case selection. The prospective nature of the study should provide a more detailed analysis of exposures in this particular population of women (risk factors related to the field, childbirth, the postpartum events ...). The events of interest were PPH and venous thromboembolic disease.
Age
16 - No limit years
Sex
FEMALE
Healthy Volunteers
Yes
CH de Carhaix
Carhaix-Plouguer, Finistère, France
CHRU de Brest - Service de Gynécologie-obstétrique
Brest, France
Clinique Keraudren
Brest, France
CH de Landerneau
Landerneau, France
CH de Morlaix
Morlaix, France
CH Quimper
Quimper, France
Start Date
January 6, 2015
Primary Completion Date
April 27, 2021
Completion Date
April 27, 2021
Last Updated
June 1, 2023
20,241
ACTUAL participants
Lead Sponsor
University Hospital, Brest
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT03728166